127 related articles for article (PubMed ID: 20113422)
1. Urinary N-telopeptides of type I collagen in healthy children.
Sato J; Hasegawa K; Tanaka H; Morishima T
Pediatr Int; 2010 Jun; 52(3):398-401. PubMed ID: 20113422
[TBL] [Abstract][Full Text] [Related]
2. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age.
Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH
Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.
Sone T; Miyake M; Takeda N; Fukunaga M
Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone Effects on Urine Cross-Linked N-Telopeptides of Type I Collagen (Ntx) Diurnal Rhythms in Children.
Wolthers OD; Heuck C
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):158-161. PubMed ID: 29366431
[TBL] [Abstract][Full Text] [Related]
6. Circadian variation in urinary excretion of bone collagen cross-links.
Bollen AM; Martin MD; Leroux BG; Eyre DR
J Bone Miner Res; 1995 Dec; 10(12):1885-90. PubMed ID: 8619368
[TBL] [Abstract][Full Text] [Related]
7. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
8. Measurement of urinary N-telopeptides from type I collagen using a colloidal gold-based immunoassay.
Lee MH; Chung CY; Lee KM; Seong WK; Kim KS; Lee SD; Park MS
J Biotechnol; 2011 May; 153(3-4):176-80. PubMed ID: 21497173
[TBL] [Abstract][Full Text] [Related]
9. Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis.
Iwamoto J; Takeda T; Ichimura S
Calcif Tissue Int; 2003 Apr; 72(4):491-7. PubMed ID: 12574873
[TBL] [Abstract][Full Text] [Related]
10. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
Rosen HN; Dresner-Pollak R; Moses AC; Rosenblatt M; Zeind AJ; Clemens JD; Greenspan SL
Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749
[TBL] [Abstract][Full Text] [Related]
11. Bone turnover in neonates: changes of urinary excretion rate of collagen type I cross-linked peptides during the first days of life and influence of gestational age.
Mora S; Prinster C; Bellini A; Weber G; Proverbio MC; Puzzovio M; Bianchi C; Chiumello G
Bone; 1997 Jun; 20(6):563-6. PubMed ID: 9177872
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Urinary Cross-Linked N-Telopeptide of Type-I Collagen and Heel Stiffness Index Measured by Quantitative Ultrasound in Middle-Aged and Elderly Men.
Nishimura T; Arima K; Abe Y; Kanagae M; Mizukami S; Okabe T; Tomita Y; Goto H; Horiguchi I; Aoyagi K
Medicine (Baltimore); 2015 Nov; 94(44):e1797. PubMed ID: 26554777
[TBL] [Abstract][Full Text] [Related]
13. A prospective longitudinal study of urinary excretion of a bone resorption marker in adolescents.
Bollen AM
Ann Hum Biol; 2000; 27(2):199-211. PubMed ID: 10768424
[TBL] [Abstract][Full Text] [Related]
14. [Normal urine levels of the aminoterminal telopeptide of type I collagen (NTx) in premature newborns in the first week of life].
Praticò G; Palano GM; Curreri R; Marletta M; Parisi G; Praticò ER
Pediatr Med Chir; 2005; 27(1-2):81-5. PubMed ID: 16922049
[TBL] [Abstract][Full Text] [Related]
15. Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty.
Mora S; Prinster C; Proverbio MC; Bellini A; de Poli SC; Weber G; Abbiati G; Chiumello G
Calcif Tissue Int; 1998 Nov; 63(5):369-74. PubMed ID: 9799819
[TBL] [Abstract][Full Text] [Related]
16. Assessment of urinary N-telopeptide: point-of-care testing, sample types, and relationship to urinary helical peptide excretion.
Zwart SR; DeKerlegand DE; Davis-Street JE; Smith SM
Clin Chim Acta; 2006 Oct; 372(1-2):65-9. PubMed ID: 16678144
[TBL] [Abstract][Full Text] [Related]
17. Determination of NTx in second-morning urine: a proposal for the standardization of morning urine collection.
Wendlová J; Mikulecký M
Wien Med Wochenschr; 2001; 151(18-20):472-5. PubMed ID: 11817260
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal evaluation of a bone resorption marker in elderly subjects.
Bollen AM; Kiyak HA; Eyre DR
Osteoporos Int; 1997; 7(6):544-9. PubMed ID: 9604050
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosis.
Chubb SA; Mandelt C; Vasikaran S
Clin Biochem; 2016 May; 49(7-8):529-33. PubMed ID: 26680567
[TBL] [Abstract][Full Text] [Related]
20. Urinary NTX results rarely alter the clinical management of patients with osteoporosis in the tertiary hospital.
Gillett MJ; Vasikaran SD
Pathology; 2006 Feb; 38(1):49-52. PubMed ID: 16484009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
